Cell Manufacturing l Part 2

The Development of Hypo-Immunogenic Pluripotent Stem Cells

Developing pluripotent-based cell therapies that can evade the host immune system is key to “off the shelf” allogeneic approaches. This program will highlight several approaches in making and testing genetically-modified, hypo-immune cells and the regulatory considerations around their clinical/commercial use.
Discounted member price: 0.00
50.00
You could save: 100.0%

Similar products

No products found